FCM
JAZZ icon

Fieldview Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fieldview Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541K Sell
2,247
-1,153
-34% -$253K 0.15% 215
2026
Q1 		$643K Sell
3,400
-7,567
-69% -$1.32M 0.19% 186
2025
Q4 		$1.86M Buy
+10,967
New +$1.68M 0.32% 107
2025
Q2 		– Sell
-43,462
Closed -$5.4M – 437
2025
Q1 		$5.4M Buy
43,462
+12,610
+41% +$1.65M 0.76% 22
2024
Q4 		$3.8M Buy
+30,852
New +$3.64M 0.59% 48

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fieldview Capital Management's JAZZ Position: Q2 2026 in Review

Fieldview Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 34% in Q2 2026, selling an estimated $253K and leaving 2,247 shares worth $541K. The position accounts for 0.15% of the portfolio, ranked #215.

Fieldview Capital Management first reported a position in JAZZ in Q4 2024 and has held it in 5 quarters since. The position peaked at $5.4M in Q1 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Fieldview Capital Management held 2,247 shares of Jazz Pharmaceuticals worth $541K as of Q2 2026.
  • Fieldview Capital Management sold 1,153 Jazz Pharmaceuticals shares in Q2 2026, an estimated $253K.
  • Jazz Pharmaceuticals made up 0.15% of Fieldview Capital Management's portfolio in Q2 2026, its #215 holding.
  • Fieldview Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Fieldview Capital Management's Jazz Pharmaceuticals position peaked at $5.4M in Q1 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.